These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32931267)

  • 1. Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling.
    Chen L; Zheng L; Chen P; Liang G
    J Med Chem; 2020 Nov; 63(22):13316-13329. PubMed ID: 32931267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
    Watters TM; Kenny EF; O'Neill LA
    Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Toll-like receptor/interleukin 1 receptor pathway in human diseases: rational design of MyD88 inhibitors.
    Loiarro M; Ruggiero V; Sette C
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):222-6. PubMed ID: 23490990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural network of inflammation and cancer: merits and challenges.
    Guven Maiorov E; Keskin O; Gursoy A; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):243-51. PubMed ID: 23712403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88.
    Fantò N; Gallo G; Ciacci A; Semproni M; Vignola D; Quaglia M; Bombardi V; Mastroianni D; Zibella MP; Basile G; Sassano M; Ruggiero V; De Santis R; Carminati P
    J Med Chem; 2008 Mar; 51(5):1189-202. PubMed ID: 18275134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
    Lin SC; Lo YC; Wu H
    Nature; 2010 Jun; 465(7300):885-90. PubMed ID: 20485341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF152 positively regulates TLR/IL-1R signaling by enhancing MyD88 oligomerization.
    Xiong MG; Xu ZS; Li YH; Wang SY; Wang YY; Ran Y
    EMBO Rep; 2020 Mar; 21(3):e48860. PubMed ID: 31930677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell death triggered by Yersinia enterocolitica identifies processing of the proinflammatory signal adapter MyD88 as a general event in the execution of apoptosis.
    Novikova L; Czymmeck N; Deuretzbacher A; Buck F; Richter K; Weber AN; Aepfelbacher M; Ruckdeschel K
    J Immunol; 2014 Feb; 192(3):1209-19. PubMed ID: 24363429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 as a bottle neck in Toll/IL-1 signaling.
    Takeuchi O; Akira S
    Curr Top Microbiol Immunol; 2002; 270():155-67. PubMed ID: 12467250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88.
    Nishiya T; Kajita E; Horinouchi T; Nishimoto A; Miwa S
    FEBS Lett; 2007 Jul; 581(17):3223-9. PubMed ID: 17583698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A universal role for MyD88 in TLR/IL-1R-mediated signaling.
    Janssens S; Beyaert R
    Trends Biochem Sci; 2002 Sep; 27(9):474-82. PubMed ID: 12217523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.
    Fekonja O; Benčina M; Jerala R
    J Biol Chem; 2012 Sep; 287(37):30993-1002. PubMed ID: 22829600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88.
    Dishon S; Schumacher A; Fanous J; Talhami A; Kassis I; Karussis D; Gilon C; Hoffman A; Nussbaum G
    Sci Rep; 2018 Jun; 8(1):9476. PubMed ID: 29930295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs.
    Avbelj M; Horvat S; Jerala R
    J Immunol; 2011 Sep; 187(5):2394-404. PubMed ID: 21804016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
    Carlsson E; Ding JL; Byrne B
    Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of N-terminal segment and membrane association in MyD88-mediated signaling.
    Avbelj M; Panter G; Jerala R
    Biochem Biophys Res Commun; 2018 Jan; 495(1):878-883. PubMed ID: 29155181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
    Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
    Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
    Stoffels B; Hupa KJ; Snoek SA; van Bree S; Stein K; Schwandt T; Vilz TO; Lysson M; Veer CV; Kummer MP; Hornung V; Kalff JC; de Jonge WJ; Wehner S
    Gastroenterology; 2014 Jan; 146(1):176-87.e1. PubMed ID: 24067878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.